Merck KGaA sells its CDMO business and US sites to Lonza
read at Endpoints ↗DealNeutral
Merck KGaA announced it will divest its contract development and manufacturing organization (CDMO) operations, transferring ownership of five U.S. manufacturing facilities to Lonza.
The transaction involves roughly 1,100 employees who will move to Lonza as part of the deal. Financial terms were not disclosed.
The move reflects Merck KGaA’s strategic shift away from CDMO services, while Lonza expands its manufacturing footprint in the United States.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Merck KGaA to exit CDMO business, divesting US sites to Lonza”
read at Endpoints ↗84 words · retrieved 53m ago
comments(0)
5-min edit window · permanent after that